MedTech Adds Six Industry Leaders to Board of Directors
Wednesday, December 7, 2016
MedTech Association, a membership-based trade association for the bioscience and medical technology (Bio/Med) industry in New York State, has added six highly-qualified community and industry leaders to its 2016-2017 board of directors. MedTech appreciates the distinguished efforts of its 2015-2016 board and looks forward to advancing the organization's mission with its new directors. For a complete listing of MedTech directors, visit http://www.medtech.org/about/board-of-directors/.
Two Albany-area executives were named to the board:
James Grabowski, Ph.D.
Director, Mergers & Acquisitions, Albany Molecular Research Inc.
Dr. Grabowski is director, mergers and acquisitions at Albany Molecular Research Inc. (AMRI) in Albany, N.Y. Dr. Grabowski has held a number of roles of increasing importance with experience managing diverse, international teams within AMRI since joining the company in 2006. His current role includes, but is not limited to, the development and analysis of an acquisition pipeline, the management of due diligence on target acquisitions and leading the integration of acquired companies. Dr. Grabowski received an MBA from the University at Albany, a Ph.D. in Organic Chemistry from Brandeis University and a bachelor's degree in Chemistry from the College of the Holy Cross.
Plant Controller, Regeneron Pharmaceuticals
Mr. Leggett is plant controller for Regeneron Pharmaceuticals. In this role, he has financial responsibility for the Rensselaer Industrial Operations and Product Supply Group. Prior to Regeneron, Leggett was the global controller for the coated fabrics division of Saint-Gobain Performance Plastics, a publicly-traded French multinational building products company. With more than 20 years of experience in finance and accounting, including 6 years in public accounting as an auditor, his specialties include telecommunications, manufacturing and biopharmaceuticals manufacturing. Leggett graduated from the University of Colorado, Boulder with a bachelor's degree in Accounting. He has also held a Certified Public Accounting license since 1995.
One Corning-area executive was named to the board:
Director, Strategic Planning & Business Development, Corning Life Sciences
Ms. Julien has served as director of strategic planning & business development for Corning Life Sciences since May 2014. In this role, Julien is responsible for strategy development and deployment within the global Corning Life Sciences organization. Prior to her current position, Julien was the director of brand and marketing communications for Corning Life Sciences, where she was responsible for establishing the brand strategy and managing the marketing efforts post-Discovery Labware acquisition. Julien received a bachelor’s degree in Chemistry from the University of Notre Dame, a master’s degree in Chemistry from South Dakota School of Mines & Technology and an MBA from the University of Notre Dame.
Two Buffalo-area executives were named to the board:
Brian McIlroy, Ph.D.
Executive Director, Buffalo Institute for Genomics and Data Analytics, University at Buffalo
Dr. McIlroy took on the role of executive director of the Buffalo Institute for Genomics and Data Analytics (BIG) at the University at Buffalo in April 2016. As executive director of BIG, Dr. McIlroy develops and implements a comprehensive plan for advancing BIG’s mission, with a focus on driving innovation and generating economic impact through industry collaboration. Dr. McIlroy was recruited to GE Global Research in May 2007 as the senior bioinstrumentation leader. He began his career at the National Medical Laser Center in London, England. While there, he was responsible for all laser treatments and maintenance of the clinical and non-clinical laser systems. Overall, Dr. McIlroy has more than 20 years’ experience in all aspects of medical device development together with management of clinical trials ranging from preclinical through phase III FDA controlled global trials. He is a world-renowned specialist in the area of Photodynamic Dosimetry Therapy (PDT) and serves on the editorial board of Journal of Photochemistry and Photobiology B, as well as being a member of many international bodies in the areas of photochemistry and photobiology. Dr. McIlroy has a Ph.D. in PDT from the National Medical Laser Center in London, England.
President & CEO, Efferent Labs, Inc.
Mr. Rader is the president and CEO of Efferent Labs, Inc., a pre-clinical stage company focused on biosensor systems for life science. A serial entrepreneur, Rader sold his first company at age 18. To date he has launched five ventures, including the most recent Efferent Labs and orchestrated multiple mergers and acquisitions. In October 2014, Efferent Labs was a winner in the world’s largest business contest, 43North. Rader started in the engineering sector of the U.S. Navy as a nuclear engineering member of the Submarine Fleet and is a member of many industry organizations. He is also a contributing writer for Forbes, where he writes on entrepreneurship and business. Rader holds a bachelor’s degree in Electrical Engineering and is a graduate of the University at Buffalo School of Management. He is also a member of Harvard Business School, Business Innovations in Global Healthcare class of 2015.
One Rochester-area executive was named to the board:
Norman C.W. Yung
Vice President and General Manager, Labware & Specialty Plastics, Thermo Fisher Scientific
Mr. Yung is the vice president and general manager of the labware and specialty plastics business for Thermo Fisher Scientific, a world leader in serving science. Before joining Thermo Fisher Scientific, Yung served as the chief marketing officer for Carestream Health, Inc. Prior to Carestream Health, Yung led the global refractive business in laser vision correction for Bausch and Lomb. Yung has also held management positions in the General Electric Healthcare IT business as well as the consulting firms McKinsey and Company and Deloitte Consulting. Yung has a bachelor's degree in Economics from the University of Chicago and an MBA from the Kellogg Graduate School of Management, Northwestern University.